Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-02-20 @ 3:45 PM
Study NCT ID:
NCT03066427
Status:
COMPLETED
Last Update Posted:
2020-11-13
First Post:
2017-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SOGUG-2016-A- IEC(REN)-10
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None